All In Biotech

Drug Trial Radar · NCT06122662

AMX0035 and Progressive Supranuclear Palsy

A Phase 2b/3 Study of the Safety and Efficacy of AMX0035 in Progressive Supranuclear Palsy (ORION)

Last checked: Nov 19, 2026Latest source record: Apr 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 139 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

139

Actual

Start

Dec 21, 2023

Primary completion

Sep 30, 2025

Study completion Oct 21, 2025

Sponsor

Lead sponsor
Amylyx Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Nov 8, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A35-009 (ORION) is a Phase 2b/3 trial to evaluate the efficacy and safety of AMX0035 in participants with Progressive Supranuclear Palsy (PSP), consisting of randomized, double blind placebo controlled phases, followed by an optional open-label extension phase.

Conditions

  • Progressive Supranuclear Palsy
  • PSP
  • Neurodegenerative Diseases
  • Atypical Parkinsonism

Interventions

  • AMX0035Drug

    Proprietary formulation of sodium phenylbutyrate and taurursodiol

  • PlaceboOther

    Matching Placebo Comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in total (28-item) Progressive Supranuclear Palsy Rating Scale (PSPRS) ScoreTime frame: 52 weeks

Locations

62 sites in 5 countries. Site status is shown where the registry gives one.

  • Mayo Clinic

    Scottsdale, Arizona

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Parkinson's & Movement Disorder Institute

    Fountain Valley, California

  • University of Southern California

    Los Angeles, California

  • Cedars Sinai Medical Center

    Los Angeles, California

  • Stanford Movement Disorder Center

    Palo Alto, California

  • University of California, San Francisco (UCSF)

    San Francisco, California

  • UC Health Anschutz Outpatient Pavilion Anschutz Medical Campus

    Aurora, Colorado

  • Parkinson's Disease and Movement Disorders Center of Boca Raton

    Boca Raton, Florida

  • UF Health Dorothy Mangurian Neuroimaging Suite

    Gainesville, Florida

  • Mayo Clinic Florida

    Jacksonville, Florida

  • Augusta University

    Augusta, Georgia

  • Parkinsons and Movement Disorder Center at the Queens Medical Center

    Honolulu, Hawaii

  • Northwestern University PD and Movement Disorders Center

    Chicago, Illinois

  • University of Kansas Medical Center Research Institute, Inc.

    Kansas City, Kansas

  • University of Kentucky Medical Center

    Lexington, Kentucky

  • Ochsner Medical Center

    New Orleans, Louisiana

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Lahey Hospital and Medical Center

    Burlington, Massachusetts

  • Quest Research Institute

    Farmington Hills, Michigan

  • University of Minnesota, CTSI

    Minneapolis, Minnesota

  • Mayo Clinic - Rochester

    Rochester, Missouri

  • Cleveland Clinic Lou Ruvo Center for Brain Health

    Las Vegas, Nevada

  • University of Cincinnati

    Cincinnati, Ohio

  • The Cleveland Clinic Foundation

    Cleveland, Ohio

  • Oregon Health & Science University

    Portland, Oregon

  • Pennsylvania Hospital

    Philadelphia, Pennsylvania

  • Medical University of South Carolina (MUSC)

    Charleston, South Carolina

  • Veracity Neuroscience, LLC

    Memphis, Tennessee

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • Kerwin Medical Center

    Dallas, Texas

  • Baylor College of Medicine

    Houston, Texas

  • Central Texas Neurology Consultants

    Round Rock, Texas

  • University of Utah Movement Disorders Center

    Salt Lake City, Utah

  • Virginia Commonwealth University Department of Neurology

    Richmond, Virginia

  • Groupe Hospitalier Pitie-Salpetriere

    Paris, France

  • Hôpital de la Timone

    Marseille, Bouches-du-Rhône, France

  • Hopital Caremeau

    Nîmes, Gard, France

  • Groupe Hospitalier Pellegrin - Hôpital Pellegrin

    Bordeaux, Gironde, France

  • CHU de Limoges - Hôpital Dupuytren

    Limoges, Haute Vienne, France

Showing 40 of 62 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.